vs

Side-by-side financial comparison of Allegiant Travel CO (ALGT) and CLOVER HEALTH INVESTMENTS, CORP. (CLOV). Click either name above to swap in a different company.

CLOVER HEALTH INVESTMENTS, CORP. is the larger business by last-quarter revenue ($749.2M vs $732.4M, roughly 1.0× Allegiant Travel CO). Allegiant Travel CO runs the higher net margin — 5.8% vs 3.6%, a 2.2% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (62.0% vs 4.8%). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (45.0% CAGR vs 11.0%).

Allegiant Air, styled as allegiant, is an American low-cost airline headquartered in Las Vegas, Nevada. The airline focuses on serving leisure traffic from small and medium-sized cities which it considers to be underserved, using an ultra low-cost business model with minimal inclusions in fares and a greater number of add-on fees.

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

ALGT vs CLOV — Head-to-Head

Bigger by revenue
CLOV
CLOV
1.0× larger
CLOV
$749.2M
$732.4M
ALGT
Growing faster (revenue YoY)
CLOV
CLOV
+57.3% gap
CLOV
62.0%
4.8%
ALGT
Higher net margin
ALGT
ALGT
2.2% more per $
ALGT
5.8%
3.6%
CLOV
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
45.0%
11.0%
ALGT

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
ALGT
ALGT
CLOV
CLOV
Revenue
$732.4M
$749.2M
Net Profit
$42.5M
$27.3M
Gross Margin
Operating Margin
11.1%
3.6%
Net Margin
5.8%
3.6%
Revenue YoY
4.8%
62.0%
Net Profit YoY
32.4%
EPS (diluted)
$2.30
$0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALGT
ALGT
CLOV
CLOV
Q1 26
$732.4M
$749.2M
Q4 25
$595.5M
$487.7M
Q3 25
$494.1M
$496.6M
Q2 25
$617.9M
$477.6M
Q1 25
$616.8M
$462.3M
Q4 24
$553.6M
$337.0M
Q3 24
$489.0M
$331.0M
Q2 24
$594.5M
$356.3M
Net Profit
ALGT
ALGT
CLOV
CLOV
Q1 26
$42.5M
$27.3M
Q4 25
$31.9M
$-49.3M
Q3 25
$-43.6M
$-24.4M
Q2 25
$-65.2M
$-10.6M
Q1 25
$32.1M
$-1.3M
Q4 24
$-216.2M
$-22.1M
Q3 24
$-36.8M
$-9.2M
Q2 24
$13.7M
$7.4M
Gross Margin
ALGT
ALGT
CLOV
CLOV
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
24.5%
Q2 24
30.3%
Operating Margin
ALGT
ALGT
CLOV
CLOV
Q1 26
11.1%
3.6%
Q4 25
11.2%
-10.1%
Q3 25
-5.5%
-4.9%
Q2 25
-10.9%
-2.2%
Q1 25
10.5%
-0.3%
Q4 24
-47.7%
-6.4%
Q3 24
-5.4%
-2.7%
Q2 24
5.9%
2.0%
Net Margin
ALGT
ALGT
CLOV
CLOV
Q1 26
5.8%
3.6%
Q4 25
5.4%
-10.1%
Q3 25
-8.8%
-4.9%
Q2 25
-10.5%
-2.2%
Q1 25
5.2%
-0.3%
Q4 24
-39.1%
-6.6%
Q3 24
-7.5%
-2.8%
Q2 24
2.3%
2.1%
EPS (diluted)
ALGT
ALGT
CLOV
CLOV
Q1 26
$2.30
$0.05
Q4 25
$1.82
Q3 25
$-2.41
Q2 25
$-3.62
Q1 25
$1.73
Q4 24
$-12.12
Q3 24
$-2.05
Q2 24
$0.75

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALGT
ALGT
CLOV
CLOV
Cash + ST InvestmentsLiquidity on hand
$902.1M
$177.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$339.4M
Total Assets
$697.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALGT
ALGT
CLOV
CLOV
Q1 26
$902.1M
$177.6M
Q4 25
$805.7M
$78.3M
Q3 25
$956.7M
Q2 25
$842.8M
Q1 25
$878.6M
Q4 24
$781.1M
$194.5M
Q3 24
$759.3M
$288.0M
Q2 24
$791.9M
$254.8M
Total Debt
ALGT
ALGT
CLOV
CLOV
Q1 26
Q4 25
$1.7B
Q3 25
$1.8B
Q2 25
$1.8B
Q1 25
$1.7B
Q4 24
$1.6B
Q3 24
$1.8B
Q2 24
$1.7B
Stockholders' Equity
ALGT
ALGT
CLOV
CLOV
Q1 26
$339.4M
Q4 25
$1.1B
$308.7M
Q3 25
$1.0B
$340.9M
Q2 25
$1.1B
$344.2M
Q1 25
$1.1B
$336.1M
Q4 24
$1.1B
$341.1M
Q3 24
$1.3B
$342.2M
Q2 24
$1.3B
$324.9M
Total Assets
ALGT
ALGT
CLOV
CLOV
Q1 26
$697.7M
Q4 25
$4.2B
$541.0M
Q3 25
$4.4B
$559.7M
Q2 25
$4.4B
$575.0M
Q1 25
$4.5B
$583.7M
Q4 24
$4.4B
$580.7M
Q3 24
$4.8B
$653.0M
Q2 24
$4.9B
$674.2M
Debt / Equity
ALGT
ALGT
CLOV
CLOV
Q1 26
Q4 25
1.60×
Q3 25
1.76×
Q2 25
1.68×
Q1 25
1.57×
Q4 24
1.48×
Q3 24
1.36×
Q2 24
1.30×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ALGT
ALGT

Passenger$671.8M92%
Third party products$42.3M6%
Fixed fee contracts$18.1M2%
Resort and other$175.0K0%

CLOV
CLOV

Segment breakdown not available.

Related Comparisons